COVID-19 and hydatidiform mole

Am J Reprod Immunol. 2020 Nov;84(5):e13310. doi: 10.1111/aji.13310. Epub 2020 Aug 4.

Abstract

The emergence of coronavirus disease 2019 (COVID-19) as a pandemic threatens the entire world resulting in severe consequences for people's health. Pregnant patients with COVID-19 had immune dysregulation that could result in abnormal pregnancy outcomes such as hydatidiform mole (HM), recurrent pregnancy loss, and early-onset preeclampsia. In this article, we tried to summarize the possible association between COVID-19 and the HM's development by reviewing the role of NOD-Like Receptor (NLR) Family Pyrin Domain Containing 7 (NLRP7), cytokines, zinc, and leukocytes in the pathogenesis of HM.

Keywords: COVID-19; Gestational trophoblastic diseases; Hydatidiform mole; coronavirus.

Publication types

  • Review

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism
  • COVID-19 / immunology*
  • Cytokines / metabolism
  • Female
  • Humans
  • Hydatidiform Mole / immunology*
  • Leukocytes / immunology*
  • Pandemics
  • Pregnancy
  • Pregnancy Complications, Infectious / immunology*
  • Pregnancy Outcome
  • SARS-CoV-2 / physiology*

Substances

  • Adaptor Proteins, Signal Transducing
  • Cytokines
  • NLRP7 protein, human